Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 05/16/2019 - 04/10/2022

Members can access this product for only $25. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

As medication management experts, pharmacists must remain up-to-date by understanding newly marketed medications and those in the clinical development pipeline. To fulfill this role, pharmacists must master essential clinically relevant knowledge about each new medication’s efficacy for the tested indication, tolerability, and safety. This information includes the pharmacodynamic mechanism of action, pharmacokinetics, drug interactions, and pharmacoeconomics. Armed with this knowledge, pharmacists will be well positioned to advocate for the use of the most beneficial medication by educating patients and other key stakeholders, including prescribers. In this session, participants will learn about therapeutic advances in new and emerging psychiatric and neurologic medications and how these agents fit into current clinical practice.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Describe the efficacy and safety data of recently approved and emerging pipeline psychiatric and neurologic medications.
  2. Explain appropriate monitoring requirements, patient education points, and provider education for these agents.
  3. Discuss clinical use of new and emerging medications and where these agents fit into current clinical practice.

Continuing Education Credit and Disclosures

Activity Dates: 05/16/2019 - 04/10/2022
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-19-034-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.